Funding development programs for clinical and commercial success

Securing capital at the right stages is essential to advance advanced therapy programs through first-in-human (FIH) studies, pivotal trials, and market preparation. This spotlight session focuses on how organizations can design funding strategies that align with scientific milestones, de-risk development, and position therapies for successful launch and scale.

Key takeaways:

• Map funding needs to clinical, regulatory, and commercialization milestones
• Prioritize data packages that improve investor confidence and predictive validity
• Structure financial planning to support scalability and operational readiness
• Evaluate funding instruments suited to capital-intensive modalities
• Integrate risk assessment into long-term resource allocation